
Ursodeoxycholic Acid capsule
Form: Capsules
Strength: 150 mg, 300 mg
Reference Brands: Actigall(US), rsofalk, Ursocaps, Ursode(EU)
Category: Gastrointestinal Drugs
Ursodeoxycholic acid capsules, marketed as Actigall and Ursocaps, are approved in the US by the FDA and in the EU via EMA for gallstone dissolution and liver disease. Approval requires a comprehensive dossier including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports swift approval, safe use, and global availability, promoting gallstone management and liver health worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Sucralfate tablet
Strength: 1 g
Form: Tablets
Reference Brands: Carafate(US)
View Details Get EnquirySimethicone tablet
Strength: 40 mg
Form: Tablets
Reference Brands: Mylicon(US)
View Details Get EnquiryPancreatin Tablets
Strength: 10,000, 25,000, 40,000, 50,000, 80,000 USP units.
Form: Tablets
Reference Brands: Creon(US)
View Details Get EnquiryL-Ornithine L-Aspartate powder
Strength: 5 g, 10 g, or 15 g
Form: Powder for Reconstitution for oral use
Reference Brands: Liv.52, HepaMerz(EU)
View Details Get Enquiry